source
- Outpace Bio halts Phase 1 ovarian cancer CAR‑T trialOutpace Bio announced that it has stopped its Phase 1 trial of OPB-101, an autologous CAR‑T therapy targeting mesothelin in ovarian cancer. The company said the trial will no longer enroll patient…
- Employers sue UnitedHealth, alleging overpayment of workers' medical claimsSix major U.S. companies have filed a lawsuit against UnitedHealth Group, claiming the insurer overpaid medical claims for their employees, which they say increased their costs. The plaintiffs inc…